Economic Times•Politics•8 సెప్టెం
Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drug
Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drug
Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drug
July was a busy month for HDFC Mutual Fund, which ramped up its investments by increasing its stakes in about 422 stocks. Simultaneously, the fund reduced its involvement in 164 stocks, affecting numerous prominent companies